Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus

Area of Science:

• Infectious Diseases
• Immunology
• Transplantation Medicine

Background:

• Sepsis is a frequent and severe complication of infectious diseases globally, with high morbidity and mortality rates (20-50%).
• Immunocompromised patients, particularly solid organ and hematopoietic stem cell transplant recipients, face elevated risks of infections and sepsis due to long-term immunosuppression.
• Detecting sepsis in this population is challenging due to atypical clinical presentations.

Purpose of the Study:

• To provide an updated review of sepsis in non-HIV immunocompromised patients.
• To outline the primary causes of sepsis in this patient group.
• To discuss the diagnostic and therapeutic challenges specific to neutropenia and transplant recipients.

Main Methods:

• Literature review focusing on sepsis in immunocompromised individuals.
• Analysis of causes, diagnostic hurdles, and treatment strategies.
• Examination of challenges in neutropenia, solid organ transplantation, and hematopoietic stem cell transplantation.

Main Results:

• Sepsis remains a leading cause of death in immunocompromised patients despite advances in care.
• Immunosuppression post-transplantation increases susceptibility to diverse infections, including opportunistic and hospital-acquired pathogens.
• Diagnostic delays and atypical symptoms complicate sepsis management in this cohort.

Conclusions:

• Sepsis presents unique challenges in immunocompromised patients, necessitating specialized approaches.
• Understanding the specific risks associated with neutropenia and transplantation is vital for effective sepsis management.
• Further research and optimized protocols are needed to improve sepsis outcomes in this high-risk population.